|
[1]
|
Shen, S., Ye, J., Wu, X. and Li, X. (2021) Association of N-Terminal Pro-Brain Natriuretic Peptide Level with Adverse Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis. Heart & Lung: The Journal of Acute and Critical Care, 50, 863-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mandoli, G., Sciaccaluga, C., Bandera, F., et al. (2021) Cor Pulmonale: The Role of Traditional and Advanced Echocardiography in the Acute and Chronic Settings. Heart Failure Reviews, 26, 263-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
See, K.C. (2021) Acute Cor Pulmonale in Patients with Acute Respiratory Distress Syndrome: A Comprehensive Review. World Journal of Critical Care Medicine, 10, 35-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Cavaleiro, P., Masi, P., Bagate, F., d’Humières, T. and Dessap, A.M. (2021) Acute Cor Pulmonale in Covid-19 Related Acute Respiratory Distress Syndrome. Critical Care, 25, Article No. 346. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
王瑜, 陈曦, 陈玉岚, 等. 血清尿酸水平检测在慢性肺心病患者心衰严重程度评估中的预测价值[J]. 海南医学院学报, 2013, 19(11): 1512-1514.
|
|
[6]
|
闫瑞华. 监测血尿酸在慢性肺源性心脏病患者中的临床价值[D]: [硕士学位论文]. 长春: 吉林大学, 2014.
|
|
[7]
|
魏彦艳, 李晓霞. 血尿酸监测在肺源性心脏病患者中的应用价值[J]. 实用检验医师杂志, 2015(2): 109-111.
|
|
[8]
|
Wolff, D., van Melle, J.P., Willems, T.P., et al. (2020) N-Terminal Pro-Brain Natriuretic Peptide Serum Levels Reflect Attrition of the Fontan Circulation. Cardiology in the Young, 30, 753-760. [Google Scholar] [CrossRef]
|
|
[9]
|
Budev, M.M., Arroliga, A.C., Wiedemann, H.P. and Matthay, R.A. (2003) Cor Pulmonale: An Overview. Seminars in Respiratory and Critical Care Medicine, 24, 233-244. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
钱薇, 熊昊. 罗氟司特对慢性阻塞性肺疾病急性加重期患者炎症及氧化应激反应的影响[J]. 空军医学杂志, 2021, 37(1): 63-66.
|
|
[11]
|
张静, 苏江华, 杨会芳, 王霞. SAA对慢性阻塞性肺疾病并心力衰竭的诊断及预防价值研究[J]. 解放军医药杂志, 2020, 32(7): 51-53.
|
|
[12]
|
Hales, C.A. (1985) The Site and Mechanism of Oxygen Sensing for the Pulmonary Vessels. Chest, 88, 235S-240S. [Google Scholar] [CrossRef]
|
|
[13]
|
Euler, U.S.V. and Liljestrand, G. (1946) Observations on the Pulmonary Arterial Blood Pressure in the Cat. Acta Physiologica Scandinavica, 12, 301-320. [Google Scholar] [CrossRef]
|
|
[14]
|
Stenmark, K.R., Fagan, K.A. and Frid, M.G. (2006) Hy-poxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms. Circulation Research, 99, 675-691. [Google Scholar] [CrossRef]
|
|
[15]
|
Wanstall, J.C., O’Donnell, S.R. and Kay, C.S. (1991) Increased Relaxation by Felodipine on Pulmonary Artery from Rats with Monocrotaline-Induced Pulmonary Hy-pertension Does Not Reflect Functional Impairment of the Endothelium. Pulmonary Pharmacology, 4, 60-66. [Google Scholar] [CrossRef]
|
|
[16]
|
Dhaun, N. and Webb, D.J. (2012) Effect of a Reduction in Uric Acid on Renal Outcomes during Losartan Treatment: A Post Hoc Analysis of the Reduction of End Points in Non-insulin-Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan Trial. Hypertension, 59, e1. [Google Scholar] [CrossRef]
|
|
[17]
|
张凌云, 高宝安. 肺动脉平滑肌细胞与低氧性肺血管重塑形成机制[J]. 中国动脉硬化杂志, 2013, 21(2): 177-181.
|
|
[18]
|
Walter, R.E., Wilk, J.B., Larson, M.G., et al. (2008) Systemic Inflammation and COPD: The Framingham Heart Study. Chest, 133, 19-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Gan, W.Q., Man, S.F., Senthilselvan, A. and Sin, D.D. (2004) Associa-tion between Chronic Obstructive Pulmonary Disease and Systemic Inflammation: A Systematic Review and a Me-ta-Analysis. Thorax, 59, 574-580. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Chaouat, A., Savale, L., Chouaid, C., et al. (2009) Role for Interleu-kin-6 in COPD-Related Pulmonary Hypertension. Chest, 136, 678-687. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Kwon, Y.S., Chi, S.Y., Shin, H.J., et al. (2010) Plasma C-Reactive Protein and Endothelin-1 Level in Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension. Journal of Korean Medical Science, 25, 1487-1491. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
孙武装, 孙佳玮, 张萍, 张永健. 慢性阻塞性肺疾病并发肺动脉高压、肺心病患者血浆脂肪炎症因子、一氧化氮、一氧化氮合成酶水平及临床意义的探讨[J]. 中国全科医学, 2011, 14(2): 140-142.
|
|
[23]
|
Nakamura, A., Kasamatsu, N., Hashizume, I., et al. (2000) Effects of Hemoglobin on Pulmonary Arterial Pressure and Pulmonary Vascular Resistance in Patients with Chronic Emphysema. Respiration, 67, 502-506. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Deem, S., Swenson, E.R., Alberts, M.K., Hedges, R.G. and Bishop, M.J. (1998) Red-Blood-Cell Augmentation of Hypoxic Pulmonary Vasoconstriction. American Journal of Respiratory and Critical Care Medicine, 157, 1181-1186. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Azarov, I., Huang, K.T., Basu, S., et al. (2005) Nitric Oxide Scavenging by Red Blood Cells as a Function of Hematocrit and Oxygenation. Journal of Biological Chemistry, 280, 39024-39032. [Google Scholar] [CrossRef]
|
|
[26]
|
向永红, 张云, 农智新, 等. Fractalkine与慢性阻塞性肺疾病并肺源性心脏病患者氧化应激相关性及机制探讨[J]. 中华肺部疾病杂志(电子版), 2017, 10(1): 59-63.
|
|
[27]
|
Roy, R.S. (1983) Super Oxide and Ischemia: Conversion of Xanthine Dehydrogenase to Xanthine Oxi-dase.
|
|
[28]
|
Savarese, G., Ferri, C., Rosano, G., et al. (2013) Changes in Serum Uric Acid Levels and Cardiovascular Events: A Meta-Analysis. Nutrition, Metabolism and Cardiovascular Diseases, 23, 707-714. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Shi, Y., Evans, J. and Rock, K. (2003) Molecular Identification of a Danger Signal That Alerts the Immune System to Dying Cells. Nature, 425, 516-521. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A. and Tschopp, J. (2006) Gout-Associated Uric Acid Crystals Activate the NALP3 Inflammasome. Nature, 440, 237-241. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Zharikov, S.I., Swenson, E.R., Lanaspa, M., et al. (2010) Could Uric Acid Be a Modifiable Risk Factor in Subjects with Pulmonary Hypertension? Medical Hypotheses, 74, 1069-1074. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Alcaino, H., Greig, D., Chiong, M., et al. (2008) Serum Uric Acid Correlates with Extracellular Superoxide Dismutase Activity in Patients with Chronic Heart Failure. European Journal of Heart Failure, 10, 646-651. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Kimura, Y., Tsukui, D. and Kono, H. (2021) Uric Acid in In-flammation and the Pathogenesis of Atherosclerosis. International Journal of Molecular Sciences, 22, Article No. 12394. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Förstermann, U. and Münzel, T. (2006) Endothelial Nitric Oxide Syn-thase in Vascular Disease. Circulation, 113, 1708-1714. [Google Scholar] [CrossRef]
|
|
[35]
|
Galassi, F.M. and Borghi, C. (2015) A Brief His-tory of Uric Acid: From Gout to Cardiovascular Risk Factor. European Journal of Internal Medicine European Journal of Internal Medicine, 26, 373. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Myers, A.R., Epstein, F.H., Dodge, H.J. and Mikkelsen, W.M. (1968) The Relationship of Serum Uric Acid to Risk Factors in Coronary Heart Disease. The American Journal of Medi-cine, 45, 520-528. [Google Scholar] [CrossRef]
|
|
[37]
|
Kir, E., Güven Atici, A., Güllü, Y.T., Köksal, N. and Tunçez, İ.H. (2021) The Relationship between Serum Uric Acid Level and Uric Acid/creatinine Ratio with Chronic Obstructive Pulmonary Disease Severity (Stable or Acute Exacerbation) and the Development of Cor Pulmonale. International Jour-nal of Clinical Practice, 75, e14303. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Kocak, N.D., Sasak, G., Akturk, U.A., et al. (2016) Serum Uric Acid Lev-els and Uric Acid/Creatinine Ratios in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients: Are These Pa-rameters Efficient Predictors of Patients at Risk for Exacerbation and/or Severity of Disease? Medical Science Monitor, 22, 4169-4176. [Google Scholar] [CrossRef]
|
|
[39]
|
Sarangi, R., Varadhan, N., Bahinipati, J., Dhinakaran, A. and Ravi-chandran, K. (2017) Serum Uric Acid in Chronic Obstructive Pulmonary Disease: A Hospital Based Case Control Study. Journal of Clinical and Diagnostic Research: JCDR, 11, BC09-BC13. [Google Scholar] [CrossRef]
|
|
[40]
|
Bhatia, A., Prakash, V., Kant, S. and Verma, A.K. (2016) A Search for Covert Precipitating Clinical Parameters in Frequent Exacerbators of Chronic Obstructive Pulmonary Disease. Lung India, 33, 600-604. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Kang, T.U., Park, K.Y., Kim, H.J., Ahn, H.S., Yim, S.-Y. and Jun, J.B. (2019) Association of Hyperuricemia and Pulmonary Hypertension: A Systematic Review and Meta-Analysis. Modern Rheumatology, 29, 1031-1041. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Huang, H., Huang, B., Wang, J., et al. (2014) Uric Acid and Risk of Heart Failure: A Systematic Review and Meta-Analysis. European Journal of Heart Failure, 16, 15-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Garcia-Pachon, E., Padilla-Navas, I. and Shum, C. (2007) Serum Uric Acid to Creatinine Ratio in Patients with Chronic Obstructive Pulmonary Disease. Lung, 185, 21-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Sautin, Y.Y. and Johnson, R.J. (2008) Uric Acid: The Oxi-dant-Antioxidant Paradox. Nucleosides, Nucleotides & Nucleic Acids, 27, 608-619. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Halliwell, B. and Gutteridge, J.M.C. (1985) Free Radicals in Bi-ology and Medicine. Journal of Free Radicals in Biology & Medicine, 1, 331-332. [Google Scholar] [CrossRef]
|
|
[46]
|
白炳鑫. 不同浓度尿酸对肾小球内皮细胞炎症及氧化应激指标的影响[D]: [硕士学位论文]. 天津: 天津医科大学, 2018.
|
|
[47]
|
Hsieh, T.-J., Zhang, S.-L., Filep, J.G., et al. (2002) High Glucose Stimulates Angiotensinogen Gene Expression via Reactive Oxygen Species Generation in Rat Kid-ney Proximal Tubular Cells. Endocrinology, 143, 2975-2985. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Ogawa, S., Mori, T., Nako, K., et al. (2006) Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy. Hypertension, 47, 699-705. [Google Scholar] [CrossRef]
|
|
[49]
|
Barnes, P.J. (2022) Oxidative Stress in Chronic Ob-structive Pulmonary Disease. Antioxidants, 11, Article No. 965. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Kang, D.-H., Park, S.-K., Lee, I.-K. and Johnson, R.J. (2005) Uric Acid-Induced C-Reactive Protein Expression: Implication on Cell Proliferation and Nitric Oxide Production of Human Vascular Cells. Journal of the American Society of Nephrology, 16, 3553-3562. [Google Scholar] [CrossRef]
|
|
[51]
|
Kanellis, J., Watanabe, S., Li, J.H., et al. (2003) Uric Acid Stimu-lates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells via Mitogen-Activated Protein Kinase and Cyclooxygenase-2. Hypertension, 41, 1287-1293. [Google Scholar] [CrossRef]
|
|
[52]
|
Gasse, P., Riteau, N., Pétrilli, V., et al. (2009) Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis. Revue des Mala-dies Respiratoires, 25, 1191. [Google Scholar] [CrossRef]
|
|
[53]
|
Schober, A. (2008) Chemokines in Vascular Dysfunction and Remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 1950-1959. [Google Scholar] [CrossRef]
|
|
[54]
|
万强, 高艳霞, 吴燕升, 等. 高尿酸血症与心血管疾病关系的研究进展[J]. 中西医结合心脑血管病杂志, 2018, 16(1): 54-56.
|
|
[55]
|
El Din, U.A.S., Salem, M.M. and Ab-dulazim, D.O. (2017) Uric Acid in the Pathogenesis of Metabolic, Renal, and Cardiovascular Diseases: A Review. Jour-nal of Advanced Research, 8, 537-548. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Cai, W., Duan, X.-M., Liu, Y., et al. (2017) Uric Acid Induces En-dothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway. BioMed Research International, 2017, Ar-ticle ID: 4391920. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Khosla, U.M., Zharikov, S., Finch, J.L., et al. (2005) Hyperuricemia Induces Endothelial Dysfunction. Kidney International, 67, 1739-1742. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Humbert, M., Guignabert, C., Bonnet, S., et al. (2019) Pa-thology and Pathobiology of Pulmonary Hypertension: State of the Art and Research Perspectives. European Respiratory Journal, 53, Article ID: 1801887. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Kang, D.-H., Nakagawa, T., Feng, L., et al. (2019) A Role for Uric Acid in the Progression of Renal Disease. Journal of the American Society of Nephrology, 13, 2888-2897. [Google Scholar] [CrossRef]
|
|
[60]
|
Mazzali, M., Kanellis, J., Han, L., et al. (2002) Hyperuricemia Induces a Primary Renal Arteriolopathy in Rats by a Blood Pressure-Independent Mechanism. American Journal of Physiology-Renal Physiology, 282, F991-F997. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Watanabe, S., Kang, D.-H., Feng, L., et al. (2002) Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity. Hypertension, 40, 355-360. [Google Scholar] [CrossRef]
|
|
[62]
|
Mazzali, M., Hughes, J., Kim, Y.-G., et al. (2001) Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism. Hypertension, 38, 1101-1106. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Corry, D.B., Eslami, P., Yamamoto, K., et al. (2008) Uric Acid Stimulates Vascular Smooth Muscle Cell Proliferation and Oxidative Stress via the Vascular Renin-Angiotensin System. Journal of Hypertension, 26, 269-275. [Google Scholar] [CrossRef]
|
|
[64]
|
Chao, H.-H., Liu, J.-C., Lin, J.-W., et al. (2008) Uric Acid Stimulates Endothelin-1 Gene Expression Associated with Nadph Oxidase in Human Aortic Smooth Muscle Cells. Acta Pharmacologica Sinica, 29, 1301-1312. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Cheng, T.-H., Lin, J.-W., Chao, H.-H., et al. (2010) Uric Acid Activates Extracellular Signal-Regulated Kinases and Thereafter Endothelin-1 Expression in Rat Cardiac Fibroblasts. International Journal of Cardiology, 139, 42-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Eräranta, A., Kurra, V., Tahvanainen, A.M., et al. (2008) Oxonic Acid-Induced Hyperuricemia Elevates Plasma Aldosterone in Experimental Renal Insufficiency. Journal of Hypertension, 26, 1661-1668. [Google Scholar] [CrossRef]
|